PHI with breast implants
How does this condition affect your private health insurance?
Breast implants are medical devices surgically placed under breast tissue or chest muscle, primarily for augmentation or reconstruction. They consist of a silicone shell filled with silicone gel or saline. While generally safe, potential complications include capsular contracture, implant rupture, infection, pain, and rarely, Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Implants are not lifetime devices and may necessitate future removal or replacement due to complications or aesthetic reasons, requiring ongoing vigilance and potential re-intervention over a patient's lifetime.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Initial surgical recovery typically takes several weeks, with full healing and resolution of most post-operative discomfort by 6-8 weeks.
Duration of Illness (Lifetime)
Implants are not permanent; their presence and potential for associated complications mean the 'illness' or potential for issues can extend over a lifetime, with average implant lifespan being 10-20 years before potential replacement or removal.
Cost of Treatment (Initial)
Initial augmentation surgery typically ranges from $6,000 to $10,000 (US), excluding anesthesia, facility fees, and pre-operative consultations. Reconstruction costs vary and may be insurance-covered.
Cost of Treatment (Lifetime)
Lifetime costs can include routine monitoring (e.g., MRI for silicone implants every 2-3 years after 5-6 years post-op), and potential revision surgeries for complications or aesthetic changes, which can range from $5,000 to $15,000 or more per revision.
Mortality Rate
Extremely low, associated with general anesthesia and major surgery. For elective procedures, it is estimated to be less than 0.01%.
Risk of Secondary Damages
Moderate to high over a lifetime. Common complications include capsular contracture (5-15%), implant rupture (5-10% within 10 years), infection (1-2%), pain, and scarring. BIA-ALCL is very rare (approx. 1 in 3,000 to 1 in 30,000 textured implants).
Probability of Full Recovery
High for recovery from the initial surgical trauma (e.g., wound healing, swelling reduction), typically >95%. However, 'complete recovery without consequences' related to the foreign body presence or potential complications is not guaranteed; revisions may be needed.
Underlying Disease Risk
Breast implants do not typically cause other systemic underlying diseases. However, specific implant-related conditions such as BIA-ALCL or severe capsular contracture are distinct complications that require diagnosis and treatment.